Literature DB >> 17084101

Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses.

Isabelle Migeotte1, David Communi, Marc Parmentier.   

Abstract

The formyl peptide receptor (FPR) family is involved in host defence against pathogens, but also in sensing internal molecules that may constitute signals of cellular dysfunction. It includes three subtypes in human and other primates. FPR responds to formyl peptides derived from bacterial and mitochondrial proteins. FPRL1 displays a large array of exogenous and endogenous ligands, including the chemokine variant sCKbeta8-1, the neuroprotective peptide humanin, and lipoxin A4. Two high affinity agonists (F2L and humanin) were recently described for FPRL2. In mouse, eight FPR-related receptors have been described. Fpr1 is the ortholog of human FPR, while fpr2 appears to share many ligands with human FPRL1. Altogether, the physiological role of the FPR family is still incompletely understood, due in part to the large variety of ligands, the redundancy with other chemoattractant agents, and the lack of clear orthologs between human and mouse receptors. Newly developed tools will allow to study further this family of receptors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17084101     DOI: 10.1016/j.cytogfr.2006.09.009

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  172 in total

Review 1.  Brain-immune interactions and the neural basis of disease-avoidant ingestive behaviour.

Authors:  Gustavo Pacheco-López; Federico Bermúdez-Rattoni
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-12-12       Impact factor: 6.237

2.  Molecular docking of 2-(benzimidazol-2-ylthio)-N-phenylacetamide-derived small-molecule agonists of human formyl peptide receptor 1.

Authors:  Andrei I Khlebnikov; Igor A Schepetkin; Liliya N Kirpotina; Lars Brive; Claes Dahlgren; Mark A Jutila; Mark T Quinn
Journal:  J Mol Model       Date:  2011-11-30       Impact factor: 1.810

3.  Commensal-epithelial signaling mediated via formyl peptide receptors.

Authors:  Christy C Wentworth; Rheinallt M Jones; Young Man Kwon; Asma Nusrat; Andrew S Neish
Journal:  Am J Pathol       Date:  2010-10-29       Impact factor: 4.307

4.  The major leukocyte chemotactic and activating factors in the mouse gut lumen are not N-formylpeptide receptor 1 agonists.

Authors:  Teresa Ojode; Erich H Schneider; H Lee Tiffany; Sunny Yung; Ji-Liang Gao; Philip M Murphy
Journal:  J Innate Immun       Date:  2012-06-20       Impact factor: 7.349

5.  Primary infection by a human immunodeficiency virus with atypical coreceptor tropism.

Authors:  Chunlai Jiang; Nicholas F Parrish; Craig B Wilen; Hui Li; Yue Chen; Jeffrey W Pavlicek; Anna Berg; Xiaozhi Lu; Hongshuo Song; John C Tilton; Jennifer M Pfaff; Elizabeth A Henning; Julie M Decker; M Anthony Moody; Mark S Drinker; Robert Schutte; Stephanie Freel; Georgia D Tomaras; Rebecca Nedellec; Donald E Mosier; Barton F Haynes; George M Shaw; Beatrice H Hahn; Robert W Doms; Feng Gao
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

6.  Neutrophil responses to staphylococcal pathogens and commensals via the formyl peptide receptor 2 relates to phenol-soluble modulin release and virulence.

Authors:  Maren Rautenberg; Hwang-Soo Joo; Michael Otto; Andreas Peschel
Journal:  FASEB J       Date:  2010-12-23       Impact factor: 5.191

7.  Inhibition of neutrophil migration in mice by mouse formyl peptide receptors 1 and 2 dual agonist: indication of cross-desensitization in vivo.

Authors:  Yoshitaka Sogawa; Takao Ohyama; Hiroaki Maeda; Kazuki Hirahara
Journal:  Immunology       Date:  2010-10-29       Impact factor: 7.397

8.  Cross-desensitization of CCR1, but not CCR2, following activation of the formyl peptide receptor FPR1.

Authors:  Filip Bednar; Changcheng Song; Giuseppe Bardi; William Cornwell; Thomas J Rogers
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

9.  Identification of novel formyl peptide receptor-like 1 agonists that induce macrophage tumor necrosis factor alpha production.

Authors:  Igor A Schepetkin; Liliya N Kirpotina; Jun Tian; Andrei I Khlebnikov; Richard D Ye; Mark T Quinn
Journal:  Mol Pharmacol       Date:  2008-05-05       Impact factor: 4.436

10.  Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis.

Authors:  Keqiang Chen; Mingyong Liu; Ying Liu; Teizo Yoshimura; Wei Shen; Yingying Le; Scott Durum; Wanghua Gong; Chunyan Wang; Ji-Liang Gao; Philip M Murphy; Ji Ming Wang
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.